H. Urwin

发表

The role of CHMP2B in frontotemporal dementia.

J. Collinge, A. Isaacs, S. Ghazi-Noori, 2009, Biochemical Society transactions.

The role of CHMP 2 B in frontotemporal dementia

J. Collinge, A. Isaacs, S. Ghazi-Noori, 2008 .

Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations

C. van Broeckhoven, J. Collinge, P. Johannsen, 2010, Human molecular genetics.

ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules

T. Hortobágyi, C. Shaw, C. Troakes, 2013, Human molecular genetics.

FUS pathology deﬁnes the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

P. Deyn, J. Trojanowski, M. Rossor, 2010 .

The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration

Nick C Fox, M. Rossor, T. Révész, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.

Patrick Santens, Karin Peeters, Rik Vandenberghe, 2008, Human molecular genetics.

Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species

D. Rubinsztein, C. Shaw, C. Vance, 2014, Journal of Cell Science.

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

R. Petersen, J. Trojanowski, M. Rossor, 2010, Acta Neuropathologica.